World's Best Scientists 2026 revealed!
Pharmacogenetics and Genomics
H-index 10

Pharmacogenetics and Genomics

1744-6872

Published by: Lippincott Williams & Wilkins

https://journals.lww.com/jpharmacogenetics/pages/default.aspx

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Genetics 136 11 13 5
Medicine 2459 59 47 9

Additional Metrics

Number of Best Scientists*: 88
Documents by Best Scientists*: 59
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 154
SCIMAGO SJR: 0.553
Impact Factor: 1.7

Overview

Top Research Topics at Pharmacogenetics and Genomics?

The journal focuses largely on the fields of Internal medicine, Pharmacogenetics, Pharmacology, Genetics and Single-nucleotide polymorphism. The studies on Internal medicine discussed can also contribute to research in the domains of Gastroenterology, Endocrinology, Oncology and Genotype. The work on Endocrinology addressed in Pharmacogenetics and Genomics expands to the thematically related Receptor.

In particular, the Genotype works presented emphasize discussions on Genotyping. Pharmacogenetics research presented in the journal encompasses a variety of subjects, including Pharmacogenomics, Bioinformatics, Polymorphism (computer science), Immunology and Drug. Pharmacogenetics and Genomics is mostly focused on Pharmacology, specifically Pharmacokinetics.

Gene, Allele, Genetic variation, Allele frequency and Exon are all subfields of Genetics research that were featured in Pharmacogenetics and Genomics. The study on Gene presented in Pharmacogenetics and Genomics intersects with the topics under Molecular biology. Topics in Single-nucleotide polymorphism were tackled in line with various other fields like Case-control study, Haplotype and Candidate gene.

  • Internal medicine (40.61%)
  • Pharmacogenetics (35.72%)
  • Pharmacology (24.32%)

What are the most cited papers published in the journal?

  • Doxorubicin pathways: pharmacodynamics and adverse effects (730 citations)
  • Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. (702 citations)
  • Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. (526 citations)

Research areas of the most cited articles at Pharmacogenetics and Genomics:

The published papers investigate areas of study like Pharmacogenetics, Pharmacology, Internal medicine, Genetics and Endocrinology. The Pharmacogenetics study featured in the most cited papers falls within the larger field of Genotype. While the journal publications focused on Internal medicine, they were also able to explore topics like Gastroenterology, Oncology and Allele frequency.

What topics the last edition of the journal is best known for?

  • Gene
  • Internal medicine
  • Enzyme

The previous edition focused in particular on these issues:

The journal mainly deals with areas of study such as Internal medicine, Pharmacogenetics, Genotype, Single-nucleotide polymorphism and Gastroenterology. It links adjacent topics like Internal medicine with Oncology. It aims to investigate interdisciplinary topics such as Pharmacogenetics and Clinical Practice.

It explores issues in Genotype which can be linked to other research areas like Tumor necrosis factor alpha, Myeloid leukemia, Allele and Induction chemotherapy. Single-nucleotide polymorphism research featured in Pharmacogenetics and Genomics incorporates concerns from various other topics such as Metformin, Colorectal cancer, Oxaliplatin, Hazard ratio and Estrogen. Pharmacogenetics and Genomics facilitates discussions on Gastroenterology that incorporate concepts from other fields like TaqMan, TaqI, Isoniazid, Multiple sclerosis and Haplotype.

The most cited articles from the last journal are:

  • Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine. (3 citations)
  • ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. (2 citations)
  • A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pharmacogenetics and Genomics (based on the number of publications) are:

  • Russ B. Altman (80 papers) absent at the last edition,
  • Teri E. Klein (80 papers) absent at the last edition,
  • Caroline F. Thorn (26 papers) absent at the last edition,
  • Richard M. Weinshilboum (21 papers) published 2 papers at the last edition,
  • Rachel F. Tyndale (20 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacogenetics and Genomics (based on the number of publications) are:

  • Stanford University (60 papers) absent at the last edition,
  • University of California, San Francisco (42 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Mayo Clinic (38 papers) published 3 papers at the last edition,
  • Vanderbilt University (36 papers) published 1 paper at the last edition the same number as at the previous edition,
  • National Institutes of Health (34 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.50% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.32% were posted by at least one author from the top 10 institutions publishing in the journal. Another 0.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.32% of all publications and 51.35% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.

    Birte Möhlendick;Kristina Schönfelder;Katharina Breuckmann;Carina Elsner

    (2021)
    113 Citations
  • PharmGKB summary: sertraline pathway, pharmacokinetics.

    Rachel Huddart;J. Kevin Hicks;Laura B. Ramsey;Jeffrey R. Strawn

    (2020)
    46 Citations
  • Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.

    Cathelijne H. Van Der Wouden;Stefan Böhringer;Erika Cecchin;Ka Chun Cheung

    (2020)
    33 Citations
  • PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics

    Taraswi Mitra-Ghosh;Samuel P. Callisto;Jatinder K. Lamba;Rory P. Remmel

    (2020)
    31 Citations
  • Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.

    Takaya Moriyama;Wenjian Yang;Colton Smith;Ching-Hon Pui

    (2021)
    14 Citations
  • PharmGKB summary: very important pharmacogene information for CACNA1S

    Katrin Sangkuhl;Robert T. Dirksen;Maria L. Alvarellos;Russ B. Altman

    (2020)
    13 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine in the USA, exploring related online degrees can provide valuable alternatives and supplementary skills. Programs like the accelerated healthcare administration degree online offer a fast-track route to leadership roles in healthcare facilities, blending management expertise with medical knowledge.

Cost is a significant consideration for many prospective students. Affordable options such as the health care administration online degree provide accessible ways to enter the healthcare industry without breaking the bank, supporting career flexibility and advancement.

Nursing is another critical pathway, especially for those wanting direct patient care roles. Online programs like the online MSN FNP programs prepare nurses to become family nurse practitioners, expanding their scope of practice and career opportunities.

For those still building foundational knowledge, the best online nursing prerequisites are essential, providing the necessary coursework to enter advanced nursing degrees or other healthcare-related fields.

Best Scientists Contributing to This Journal

Recently Published Articles